Mao Yijun, Liu Qiang, Fan Hui, Li Erqing, He Wenjing, Ouyang Xueqian, Wang Xiaojuan, Qiu Li, Dong Huanni
Catheterization Laboratory, Xianyang Central Hospital, Xianyang City, Shaanxi Province, China.
Orthopedic Surgery, Xianyang Central Hospital, Xianyang City, Shaanxi Province, China.
Public Health Nurs. 2025 Jan-Feb;42(1):535-546. doi: 10.1111/phn.13441. Epub 2024 Oct 14.
This study aims to evaluate the predictive performance and methodological quality of post-stroke readmission prediction models, identify key predictors associated with readmission, and provide guidance for selecting appropriate risk assessment tools.
A comprehensive literature search was conducted from inception to February 1, 2024. Two independent researchers screened the literature and extracted relevant data using the CHARMS checklist.
Eleven studies and 16 prediction models were included, with sample sizes ranging from 108 to 803,124 cases and outcome event incidences between 5.2% and 50.0%. The four most frequently included predictors in the models were length of stay, hypertension, age, and functional disability. Twelve models reported an area under the curve (AUC) ranging from 0.520 to 0.940, and five models provided calibration metrics. Only one model included both internal and external validation, while six models had internal validation. Eleven studies were found to have a high risk of bias (ROB), predominantly in the area of data analysis.
This systematic review included 16 readmission prediction models for stroke, which generally exhibited good predictive performance and can effectively identify high-risk patients likely to be readmitted. However, the generalizability of these models remains uncertain due to methodological limitations. Rather than developing new readmission prediction models for stroke, the focus should shift toward external validation and the iterative adaptation of existing models. These models should be tailored to local settings, extended with new predictors if necessary, and presented in an interactive graphical user interface.
PROSPERO registration number CRD42023466801.
本研究旨在评估卒中后再入院预测模型的预测性能和方法学质量,识别与再入院相关的关键预测因素,并为选择合适的风险评估工具提供指导。
从研究起始至2024年2月1日进行了全面的文献检索。两名独立研究人员使用CHARM清单筛选文献并提取相关数据。
纳入了11项研究和16个预测模型,样本量从108例至803,124例不等,结局事件发生率在5.2%至50.0%之间。模型中最常纳入的四个预测因素是住院时间、高血压、年龄和功能残疾。12个模型报告的曲线下面积(AUC)范围为0.520至0.940,5个模型提供了校准指标。只有1个模型同时进行了内部和外部验证,6个模型有内部验证。发现11项研究存在高偏倚风险(ROB),主要在数据分析领域。
本系统评价纳入了16个卒中再入院预测模型,这些模型总体表现出良好的预测性能,能够有效识别可能再次入院的高危患者。然而,由于方法学限制,这些模型的可推广性仍不确定。不应致力于开发新的卒中再入院预测模型,而应将重点转向外部验证和对现有模型的迭代调整。这些模型应根据当地情况进行定制,必要时用新的预测因素进行扩展,并以交互式图形用户界面呈现。
PROSPERO注册号CRD42023466801。